Utpal Basu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Utpal Basu has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
Olga Lozynska
Department of Physiology, Pennsylvania Muscle Institute, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
4 shared publicationsSanthosh M. Baby
Department of Physiology and Pennsylvania Muscle Institute, University of Pennsylvania School of Medicine, A-601 Richards Building, 3700 Hamilton Walk, Philadelphia, Pennsylvania 19104-6085, USA
3 shared publicationsShankhamala Bose
University of Kalyani
3 shared publications- Tejvir S. Khurana
Department of Physiology and Pennsylvania Muscle Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States of America
3 shared publications Trinath Ghosh
Department of Molecular Biology & Biotechnology, University of Kalyani, Kalyani, West Bengal, India
3 shared publicationsUjjal Ghosh
3 shared publications
Latest Publications
- Open Access
KH1 Domain of Poly C Binding Protein 1 (PCBP1) Interacts with Utrophin-A mRNA and Modulates Utrophin-A Expression in Mouse Myoblasts
Utrophin upregulation is an attractive strategy to ameliorate Duchenne Muscular Dystrophy (DMD). Here, we investigated whether the murine poly(C)-binding protein 1 (PCBP1) directly interacts with the utrophin-A mRNA, and how the interaction shapes the fate of utrophin-A in muscle cells. As no experimentally validated structure of the murine PCBP1 is available, AlphaFold2 was utilized to predict the structure of the full-length protein and the KH1-KH2 domain of the protein. The more stable and reliable model of the KH1-KH2 domain of PCBP1 was then docked with the 5′UTR of the utrophin-A mRNA, and the top-ranked docked complex was utilized for MD simulation to identify the most stable hydrogen bond-forming amino acid residues from PCBP1. ITC showed a thermodynamically favorable spontaneous interaction between the full-length PCBP1 and the 5′UTR of utrophin-A mRNA, but the deletion mutant of PCBP1, lacking the predicted contact region, failed to exhibit any interaction. This observation was also confirmed by an RNA-immunoprecipitation assay in C2C12 cells. However, the mutant PCBP1 was unable to alter the expression of the utrophin-A in the C2C12 cells. In cells, PCBP1 overexpression lowered utrophin-A expression, while shRNA knockdown produced reciprocal increases. A 5′UTR-luciferase reporter mirrored this observation. Finally, subcellular fractionation showed that PCBP1 promotes nuclear retention of utrophin-A transcripts and reduces their cytoplasmic availability, with reciprocal shifts upon PCBP1 knockdown. Considering earlier work on PCBP2, our data suggest both paralogs recognize the same 5′UTR element, and the KH1-dependent interaction represses utrophin-A by coupling nuclear retention to reduced protein output. Thus, the PCBP1-5′UTR interaction emerges as a potent target for utrophin de-repression in DMD.
Open AccessKH1 Domain of Poly C Binding Protein 1 (PCBP1) Interacts with Utrophin-A mRNA and Modulates Utrophin-A Expression in Mouse Myoblasts
Utrophin upregulation is an attractive strategy to ameliorate Duchenne Muscular Dystrophy (DMD). Here, we investigated whether the murine poly(C)-binding protein 1 (PCBP1) directly interacts with the utrophin-A mRNA, and how the interaction shapes the fate of utrophin-A in muscle cells. As no experimentally validated structure of the murine PCBP1 is available, AlphaFold2 was utilized to predict the structure of the full-length protein and the KH1-KH2 domain of the protein. The more stable and reliable model of the KH1-KH2 domain of PCBP1 was then docked with the 5′UTR of the utrophin-A mRNA, and the top-ranked docked complex was utilized for MD simulation to identify the most stable hydrogen bond-forming amino acid residues from PCBP1. ITC showed a thermodynamically favorable spontaneous interaction between the full-length PCBP1 and the 5′UTR of utrophin-A mRNA, but the deletion mutant of PCBP1, lacking the predicted contact region, failed to exhibit any interaction. This observation was also confirmed by an RNA-immunoprecipitation assay in C2C12 cells. However, the mutant PCBP1 was unable to alter the expression of the utrophin-A in the C2C12 cells. In cells, PCBP1 overexpression lowered utrophin-A expression, while shRNA knockdown produced reciprocal increases. A 5′UTR-luciferase reporter mirrored this observation. Finally, subcellular fractionation showed that PCBP1 promotes nuclear retention of utrophin-A transcripts and reduces their cytoplasmic availability, with reciprocal shifts upon PCBP1 knockdown. Considering earlier work on PCBP2, our data suggest both paralogs recognize the same 5′UTR element, and the KH1-dependent interaction represses utrophin-A by coupling nuclear retention to reduced protein output. Thus, the PCBP1-5′UTR interaction emerges as a potent target for utrophin de-repression in DMD.
- Open Access
- 12 November 2021
- Published by Taylor & Francis in RNA Biology
- Vol. 18 (sup2) , 612-622
Poly C Binding Protein 2 dependent nuclear retention of the utrophin-A mRNA in C2C12 cells
Upregulation of utrophin, the autosomal homologue of dystrophin, can compensate dystrophin deficiency in Duchenne Muscular Dystrophy (DMD) although the therapeutic success is yet to be achieved. The present study has identified Poly (C) binding protein 2 (PCBP2) as a post-transcriptional suppresser for the expression of utrophin-A, the muscle-specific utrophin isoform. This study confirms nuclear retention of utrophin-A mRNA in C2C12 cells, which is mediated by PCBP2. Further investigation demonstrates PCBP2-dependent nuclear retention of follistatin mRNA as well. Its involvement in nuclear retention of mRNA sheds light on a novel function of PCBP2 that makes utrophin-A mRNA less available in cytosol. PCBP2, therefore, may be a target to de-repress utrophin-A expression in DMD.
- 12 November 2021
- Published by Taylor & Francis in RNA Biology
- Vol. 18 (sup2) , 612-622
Open AccessPoly C Binding Protein 2 dependent nuclear retention of the utrophin-A mRNA in C2C12 cells
Upregulation of utrophin, the autosomal homologue of dystrophin, can compensate dystrophin deficiency in Duchenne Muscular Dystrophy (DMD) although the therapeutic success is yet to be achieved. The present study has identified Poly (C) binding protein 2 (PCBP2) as a post-transcriptional suppresser for the expression of utrophin-A, the muscle-specific utrophin isoform. This study confirms nuclear retention of utrophin-A mRNA in C2C12 cells, which is mediated by PCBP2. Further investigation demonstrates PCBP2-dependent nuclear retention of follistatin mRNA as well. Its involvement in nuclear retention of mRNA sheds light on a novel function of PCBP2 that makes utrophin-A mRNA less available in cytosol. PCBP2, therefore, may be a target to de-repress utrophin-A expression in DMD.
- 2 June 2020
- Published by Wiley in Phytotherapy Research
- Vol. 34 (10) , 2425-2428
Can concomitant use of zinc and curcumin with other immunity‐boosting nutraceuticals be the arsenal against COVID‐19?
- 2 June 2020
- Published by Wiley in Phytotherapy Research
- Vol. 34 (10) , 2425-2428
Can concomitant use of zinc and curcumin with other immunity‐boosting nutraceuticals be the arsenal against COVID‐19?
- Open Access
- 30 September 2019
- Published by Oriental Scientific Publishing Company in Biosciences Biotechnology Research Asia
- Vol. 16 (3) , 537-543
Expression Pattern of Major Poly C Binding Protein (Pcbp) Isoforms in Cancer Cell Lines of Cervix, Melanoma and Muscle
Poly (C) binding proteins (PCBPs) are members of sequence specific RNA binding protein family with conserved KH domain. There are four identified isoforms such as Pcbp1 or α-CP1 (α-Complex proteins), Pcbp2 or α-CP2, Pcbp3 or α-CP3 and Pcbp4 or α-CP4. Among them Pcbp1 and Pcbp2 are the most studied and found to be associated with various cellular functions such as transcriptional regulations, translational regulations and mRNA stability. Although two proteins share extensive similarity, they differ in function and localization. Pcbp1 has role in tumorigenesis, and metastasis, which are key phenomena of cancer. Role of pcbp2 has been well documented in the biology of RNA virus, namely translation and replication. Here, we studied expression pattern of Pcbp1 and Pcbp2 in three different cancer cell lines namely HeLa, RD, and A375 originated from different tissues. The results indicate not only differential abundance of these two proteins in three cell lines, but also discordant expression of pcbp1 in mRNA and protein level in three cell lines. The study therefore suggests post-transcriptional regulation of pcbp1 expression in these cell lines.
- 30 September 2019
- Published by Oriental Scientific Publishing Company in Biosciences Biotechnology Research Asia
- Vol. 16 (3) , 537-543
Open AccessExpression Pattern of Major Poly C Binding Protein (Pcbp) Isoforms in Cancer Cell Lines of Cervix, Melanoma and Muscle
Poly (C) binding proteins (PCBPs) are members of sequence specific RNA binding protein family with conserved KH domain. There are four identified isoforms such as Pcbp1 or α-CP1 (α-Complex proteins), Pcbp2 or α-CP2, Pcbp3 or α-CP3 and Pcbp4 or α-CP4. Among them Pcbp1 and Pcbp2 are the most studied and found to be associated with various cellular functions such as transcriptional regulations, translational regulations and mRNA stability. Although two proteins share extensive similarity, they differ in function and localization. Pcbp1 has role in tumorigenesis, and metastasis, which are key phenomena of cancer. Role of pcbp2 has been well documented in the biology of RNA virus, namely translation and replication. Here, we studied expression pattern of Pcbp1 and Pcbp2 in three different cancer cell lines namely HeLa, RD, and A375 originated from different tissues. The results indicate not only differential abundance of these two proteins in three cell lines, but also discordant expression of pcbp1 in mRNA and protein level in three cell lines. The study therefore suggests post-transcriptional regulation of pcbp1 expression in these cell lines.
- Open Access
- 1 September 2019
- Vol. 8 (3) , 129-133
Repression-free utrophin-A 5′UTR variants
Mutation in the dystrophin gene results Duchenne Muscular Dystrophy (DMD), an X-linked fatal neuromuscular disorder. Dystrophin deficiency can be compensated by upregulation of utrophin, an autosomal homologue of dystrophin. But the expression of utrophin in adults is restricted to myotendinous and neuromuscular junctions. Therefore utrophin upregulation throughout the muscle fiber can only be achieved if we understand regulatory mechanisms behind its expression. Utrophin-A 5′UTR mediated repression of translation was reported earlier. In this article, we present evidences of two transcript variants of utrophin-A that do not confer repression to the downstream reporter ORF in mouse myoblast C2C12 cells. These repression-free variants may be targeted for utrophin upregulation.
- 1 September 2019
- Vol. 8 (3) , 129-133
Open AccessRepression-free utrophin-A 5′UTR variants
Mutation in the dystrophin gene results Duchenne Muscular Dystrophy (DMD), an X-linked fatal neuromuscular disorder. Dystrophin deficiency can be compensated by upregulation of utrophin, an autosomal homologue of dystrophin. But the expression of utrophin in adults is restricted to myotendinous and neuromuscular junctions. Therefore utrophin upregulation throughout the muscle fiber can only be achieved if we understand regulatory mechanisms behind its expression. Utrophin-A 5′UTR mediated repression of translation was reported earlier. In this article, we present evidences of two transcript variants of utrophin-A that do not confer repression to the downstream reporter ORF in mouse myoblast C2C12 cells. These repression-free variants may be targeted for utrophin upregulation.
- Open Access
- 22 August 2019
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 10, 1876
Genomic and Proteomic Characterizations of Sfin-1, a Novel Lytic Phage Infecting Multidrug-Resistant Shigella spp. and Escherichia coli C
Shigellosis is a public health threat in developed as well as developing countries like India. While antibiotic therapy is the mainstay of treatment for shigellosis, current emergence of multidrug-resistant strains of Shigella spp. has posed the problem more challenging. Lytic bacteriophages which destroy antibiotic resistant Shigella spp. have great potential in this context. In this study we presented the isolation and a detailed characterization of a novel bacteriophage Sfin-1, which shows potent lytic activity against multidrug-resistant isolates of Shigella flexneri, Shigella dysenteriae, Shigella sonnei obtained from clinical specimens from shigellosis patients. It is also active against Escherichia coli C. The purified phage is lytic in nature, exhibited rapid absorption (within 5-10 mins.), a short latent period (within 5-20 mins.) and relatively large (~28 to~146 PFU/cell) burst size. The isolated phage shows stability in a broad pH range and survives an hour at 50°C. Genome sequencing and phylogenetic analyses showed that Sfin-1 is a novel bacteriophage, which is very closely related to T1-like phages. In silico analysis indicates that Sfin-1 genome consists of double stranded linear DNA of 50,403 bp (GC content of 45.2%) encoding 81 potential CDSs, several potential promoters and transcriptional terminators. Under Electron microscopy, Sfin-1 shows morphology characteristics of the family Siphoviridae with an isometric head (61 nm) and a non-contractile tail (155 nm). This is most likely the first report of a lytic bacteriophage that is active against three of the most virulent multidrug-resistant Shigella species and therefore might have a potential role in phage therapy of patients infected with these organisms.
- 22 August 2019
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 10, 1876
Open AccessGenomic and Proteomic Characterizations of Sfin-1, a Novel Lytic Phage Infecting Multidrug-Resistant Shigella spp. and Escherichia coli C
Shigellosis is a public health threat in developed as well as developing countries like India. While antibiotic therapy is the mainstay of treatment for shigellosis, current emergence of multidrug-resistant strains of Shigella spp. has posed the problem more challenging. Lytic bacteriophages which destroy antibiotic resistant Shigella spp. have great potential in this context. In this study we presented the isolation and a detailed characterization of a novel bacteriophage Sfin-1, which shows potent lytic activity against multidrug-resistant isolates of Shigella flexneri, Shigella dysenteriae, Shigella sonnei obtained from clinical specimens from shigellosis patients. It is also active against Escherichia coli C. The purified phage is lytic in nature, exhibited rapid absorption (within 5-10 mins.), a short latent period (within 5-20 mins.) and relatively large (~28 to~146 PFU/cell) burst size. The isolated phage shows stability in a broad pH range and survives an hour at 50°C. Genome sequencing and phylogenetic analyses showed that Sfin-1 is a novel bacteriophage, which is very closely related to T1-like phages. In silico analysis indicates that Sfin-1 genome consists of double stranded linear DNA of 50,403 bp (GC content of 45.2%) encoding 81 potential CDSs, several potential promoters and transcriptional terminators. Under Electron microscopy, Sfin-1 shows morphology characteristics of the family Siphoviridae with an isometric head (61 nm) and a non-contractile tail (155 nm). This is most likely the first report of a lytic bacteriophage that is active against three of the most virulent multidrug-resistant Shigella species and therefore might have a potential role in phage therapy of patients infected with these organisms.
- 1 May 2017
- Published by Elsevier in Environmental and Experimental Botany
- Vol. 137, 96-109
Insights into the miRNA-mediated response of maize leaf to arsenate stress
- 1 May 2017
- Published by Elsevier in Environmental and Experimental Botany
- Vol. 137, 96-109
Insights into the miRNA-mediated response of maize leaf to arsenate stress
- 7 February 2017
- Published by Springer Nature in Plant Cell, Tissue and Organ Culture (PCTOC)
- Vol. 129 (2) , 313-324
In vitro shoots from root explant, their encapsulation, storage, plant recovery and genetic fidelity assessment of Limonium hybrid ‘Misty Blue’: a florist plant
- 7 February 2017
- Published by Springer Nature in Plant Cell, Tissue and Organ Culture (PCTOC)
- Vol. 129 (2) , 313-324
In vitro shoots from root explant, their encapsulation, storage, plant recovery and genetic fidelity assessment of Limonium hybrid ‘Misty Blue’: a florist plant
- 1 January 2016
- Published by Elsevier in Materials Science and Engineering: B
- Vol. 203, 41-51
Microbial biosynthesis of nontoxic gold nanoparticles
- 1 January 2016
- Published by Elsevier in Materials Science and Engineering: B
- Vol. 203, 41-51
Microbial biosynthesis of nontoxic gold nanoparticles
- Open Access
- 31 July 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (7) , e0134809
Cis-Acting Sequence Elements and Upstream Open Reading Frame in Mouse Utrophin-A 5'-UTR Repress Cap-Dependent Translation
Utrophin, the autosomal homologue of dystrophin can functionally compensate for dystrophin deficiency. Utrophin upregulation could therefore be a therapeutic strategy in Duchenne Muscular Dystrophy (DMD) that arises from mutation in dystrophin gene. In contrast to its transcriptional regulation, mechanisms operating at post-transcriptional level of utrophin expression have not been well documented. Although utrophin-A 5'-UTR has been reported with internal ribosome entry site (IRES), its inhibitory effect on translation is also evident. In the present study we therefore aimed to compare relative contribution of cap-independent and cap-dependent translation with mouse utrophin-A 5'-UTR through m7G-capped and A-capped mRNA transfection based reporter assay. Our results demonstrate that cap-independent translation with utrophin-A 5'-UTR is not as strong as viral IRES. However, cap-independent mode has significant contribution as cap-dependent translation is severely repressed with utrophin-A 5'-UTR. We further identified two sequence elements and one upstream open reading frame in utrophin-A 5'-UTR responsible for repression. The repressor elements in utrophin-A 5'-UTR may be targeted for utrophin upregulation.
- 31 July 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (7) , e0134809
Open AccessCis-Acting Sequence Elements and Upstream Open Reading Frame in Mouse Utrophin-A 5'-UTR Repress Cap-Dependent Translation
Utrophin, the autosomal homologue of dystrophin can functionally compensate for dystrophin deficiency. Utrophin upregulation could therefore be a therapeutic strategy in Duchenne Muscular Dystrophy (DMD) that arises from mutation in dystrophin gene. In contrast to its transcriptional regulation, mechanisms operating at post-transcriptional level of utrophin expression have not been well documented. Although utrophin-A 5'-UTR has been reported with internal ribosome entry site (IRES), its inhibitory effect on translation is also evident. In the present study we therefore aimed to compare relative contribution of cap-independent and cap-dependent translation with mouse utrophin-A 5'-UTR through m7G-capped and A-capped mRNA transfection based reporter assay. Our results demonstrate that cap-independent translation with utrophin-A 5'-UTR is not as strong as viral IRES. However, cap-independent mode has significant contribution as cap-dependent translation is severely repressed with utrophin-A 5'-UTR. We further identified two sequence elements and one upstream open reading frame in utrophin-A 5'-UTR responsible for repression. The repressor elements in utrophin-A 5'-UTR may be targeted for utrophin upregulation.